Allogeneic HSCT for autoimmune disease: a shared decision.
Publication
, Journal Article
Sullivan, KM; Sarantopoulos, S
Published in: Nat Rev Rheumatol
December 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Nat Rev Rheumatol
DOI
EISSN
1759-4804
Publication Date
December 2019
Volume
15
Issue
12
Start / End Page
701 / 702
Location
United States
Related Subject Headings
- Retrospective Studies
- Humans
- Hematopoietic Stem Cell Transplantation
- Autoimmune Diseases
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sullivan, K. M., & Sarantopoulos, S. (2019). Allogeneic HSCT for autoimmune disease: a shared decision. Nat Rev Rheumatol, 15(12), 701–702. https://doi.org/10.1038/s41584-019-0306-7
Sullivan, Keith M., and Stefanie Sarantopoulos. “Allogeneic HSCT for autoimmune disease: a shared decision.” Nat Rev Rheumatol 15, no. 12 (December 2019): 701–2. https://doi.org/10.1038/s41584-019-0306-7.
Sullivan KM, Sarantopoulos S. Allogeneic HSCT for autoimmune disease: a shared decision. Nat Rev Rheumatol. 2019 Dec;15(12):701–2.
Sullivan, Keith M., and Stefanie Sarantopoulos. “Allogeneic HSCT for autoimmune disease: a shared decision.” Nat Rev Rheumatol, vol. 15, no. 12, Dec. 2019, pp. 701–02. Pubmed, doi:10.1038/s41584-019-0306-7.
Sullivan KM, Sarantopoulos S. Allogeneic HSCT for autoimmune disease: a shared decision. Nat Rev Rheumatol. 2019 Dec;15(12):701–702.
Published In
Nat Rev Rheumatol
DOI
EISSN
1759-4804
Publication Date
December 2019
Volume
15
Issue
12
Start / End Page
701 / 702
Location
United States
Related Subject Headings
- Retrospective Studies
- Humans
- Hematopoietic Stem Cell Transplantation
- Autoimmune Diseases
- 3202 Clinical sciences
- 1103 Clinical Sciences